Influence of Patient Choice of Intrathecal Morphine on Post-cesarean Delivery Pain.

Completed · Not applicable

Conditions studied: Pain

In brief

This is a randomized controlled study that will place patients into a "choice" and a "no choice" group. The choice group will be able to choose between receiving 100 mcg or 200 mcg intrathecal morphine. The no choice group will be randomized to receive either 100 mcg or 200 mcg of intrathecal morphine. Following casarean delivery, pain scores will be measured at 3, 6, 12, 24, and 36 hours.

Key facts

Study ID

NCT01425762

Run by

Stanford University

People needed

120

Starts

2011-08-01

Expected to finish

2013-07-01

Last updated by the study team

2015-11-13

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women age 18-50 with singleton, term gestation fetuses and scheduled for their 1st, 2nd, or 3rd elective CS (not in labor) will be included.

You may not qualify if…

• Patient refusal.

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.